Stimulation of insulin secretion in clonal BRIN-BD11 cells by the imidazoline derivatives KU14R and RX801080

Pharmacological Research

Volumn 42, Issue 6, 2000, Pages 575-579

  Ball, Andrew J ^a   Flatt, Peter R ^a   McClenaghan, Neville H ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

BTS 67 582; Clonal pancreatic beta cells; Imidazolines; Insulin secretion

Indexed keywords

1,1 DIMETHYL 2 (2 MORPHOLINOPHENYL)GUANIDINE FUMARATE; 2 (2,3 DIHYDRO 2 BENZOFURANYL) 2 IMIDAZOLE; 2 (2,3 DIHYDRO 2 BENZOFURANYL) 2 IMIDAZOLINE; EFAROXAN; GLUCOSE; GUANIDINE DERIVATIVE; IMIDAZOLINE DERIVATIVE; INSULIN; KU 14R; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; HORMONAL REGULATION; INSULIN LIKE ACTIVITY; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0033709470     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.2000.0739     Document Type: Article

References (35)

1. A history of Naunyn Schmeidebergs archives of pharmacology
2. Central cardiovascular effects of alpha adrenergic drugs: Differences between catecholamines and imidazolines
3. + channels in mouse pancreatic β-cells
4. + channels
5. +-ATP channels in insulin-secreting cells
6. +-channels in pancreatic β-cells
7. Potassium channels, imidazolines, and insulin-secreting cells
8. Elevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: Implications for stimulus-response coupling of insulin release
9. Imidazoline compounds stimulate insulin release by inhibition of K(ATP) channels and interaction with the exocytotic machinery
10. Different modes of action of the imidazoline compound RX871024 in pancreatic β-cells
11. Multiple effector pathways regulate the insulin secretory response to the imidazoline RX871024 in isolated rat pancreatic islets
12. 2-sites
13. 2-adrenoceptors and imidazoline binding sites in the control of insulin secretion
14. Imidazoline receptors: Basic knowledge, recent advances and future prospects for therapy and diagnosis
15. Imidazolines and pancreatic hormone secretion
16. Seeing through a glass darkly: Casting light on imidazoline I sites
17. Stimulation of insulin release from the MIN6 cell line by a new imidazoline compound, S-21663: Evidence for the existence of a novel imidazoline site in β-cells
18. Synthesis and characterisation of KU14R, a novel antagonist of the pancreatic islet imidazoline binding site
19. Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline RX801080
20. Evidence that the ability of imidazoline compounds to stimulate insulin secretion is not due to interaction with σ receptors
21. Characterization of the imidazoline binding site involved in regulation of insulin secretion
22. Characterization of new efaroxan derivatives for use in purification of imidazoline-binding sites
23. Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion
24. Physiological and pharmacological regulation of insulin release: Insights offered through exploitation of insulin-secreting cell lines
25. ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta cell line
26. Abnormal plasma glucose and insulin responses in heterozygous (ob/+) mice
27. Insulin-releasing action of the novel antidiabetic agent BTS 67 582
28. Induced desensitization of the insulinotropic effects of antidiabetic drugs, BTS 67 582 and tolbutamide
29. BTS 67 582 may mediate insulin secretion via the putative pancreatic islet imidazoline receptor
30. Effects of imidazolines and derivatives on insulin secretion and vascular resistance in perfused rat pancreas
31. An insulin-releasing property of imidazoline derivatives is not limited to compounds that block α-adrenoceptors
32. Antazoline increases insulin secretion and improves glucose tolerance in rats and dogs
33. Potent antihyperglycaemic property of a new imidazoline derivative S-22068 (PMS 847) in a rat model of NIDDM
34. + channels by phentolamine and other alpha-adrenoceptor antagonists
35. Effect of the new imidazoline derivative S-22068 (PMS 847) on insulin secretion in vitro and glucose turnover in vivo in rats